Daejeon, South Korea

Sungho Woo

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sungho Woo: Innovator in Antibody-Active Agent Conjugates

Introduction

Sungho Woo is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibody-active agent conjugates. With a total of 2 patents, his work focuses on innovative methods for delivering active agents to target cells.

Latest Patents

Sungho Woo's latest patents include groundbreaking inventions related to antibody-active agent conjugates and methods of use. These inventions provide protein-active agent conjugates that feature an amino acid motif recognized by isoprenoid transferases. The patents also describe compositions containing these conjugates and methods for utilizing them to deliver active agents to target cells. Furthermore, they outline approaches for treating subjects in need of the active agent, showcasing the potential impact of his work in therapeutic applications.

Career Highlights

Sungho Woo is currently associated with Legochem Biosciences, Inc., where he continues to advance his research and development efforts. His expertise in biotechnology and innovative thinking have positioned him as a key player in his field.

Collaborations

Sungho Woo collaborates with talented individuals such as Yongzu Kim and Taekyo Park. Their combined efforts contribute to the success of their projects and the advancement of their research.

Conclusion

Sungho Woo's contributions to the field of biotechnology, particularly through his patents on antibody-active agent conjugates, highlight his innovative spirit and dedication to improving therapeutic methods. His work continues to pave the way for advancements in targeted drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…